Efficacy and safety of immune checkpoint inhibitors for advanced or recurrent endometrial cancer: a systematic review and network meta-analysis
Crossref DOI link: https://doi.org/10.1186/s12885-024-13058-z
Published Online: 2024-10-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Danxue
Li, Su
Bai, Yang
Wang, Yan
Text and Data Mining valid from 2024-10-21
Version of Record valid from 2024-10-21
Article History
Received: 8 March 2024
Accepted: 14 October 2024
First Online: 21 October 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.